🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Charles W. Drescher

Fred Hutch Cancer Center

ORCID: 0000-0002-6579-0416

Also affiliated with Swedish Medical Center, Swedish Medical Center

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.165Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube

Nature Communications(2025)10.1038/s41467-025-58145-2
Top 70%
0.165DataRank
Top 70%2 citations

Svetlana Djirackor, Dalia K. Omran, Euihye Jung, Natalie Shih, Ritu Roy +15 more

Papers

Driven by 13 papers — median percentile 30. Top paper: “Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube”.

Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube

Nature Communications(2025)10.1038/s41467-025-58145-2
Top 70%
0.165DataRank
Top 70%2 citations

Svetlana Djirackor, Dalia K. Omran, Euihye Jung, Natalie Shih, Ritu Roy +15 more

Large Prospective Study of Ovarian Cancer Screening in High-Risk Women: CA125 Cut-Point Defined by Menopausal Status

UNC Libraries(2020)10.17615/6wxj-0g75
N/A
0DataRank · unranked
0 citations

Claudine Isaacs, Patrick M. Sluss, Phuong Mai, Wendy R. Brewster, Gustavo C. Rodriguez +25 more

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials

UNC Libraries(2020)10.17615/2xde-se42
N/A
0DataRank · unranked
0 citations

Phuong L. Mai, David S. Alberts, William J. Welch, Carol J. Fabian, Mary B. Daly +32 more

Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass

Scientific Reports(2021)10.1038/s41598-021-97433-x
N/A
0DataRank · unranked
29 citations

Charles W. Drescher, Nicole Urban, Christopher I. Li, Lisa Bettcher, Nitai C. Hait +5 more

Translational Development of A Tumor Junction Opening Technology

Research Square(2021)10.21203/rs.3.rs-1075411/v1
N/A
0DataRank · unranked
0 citations

Chang Li, Hongjie Wang, Swarnendu Kaviraj, Sanjay Singh, Laxman Savergave +11 more

A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1113
N/A
0DataRank · unranked
18 citations

Chae Young Han, Joseph Celestino, Ranran Wu, Eunice Murage, Rachelle Spencer +11 more

Translational development of a tumor junction opening technology

Scientific Reports(2022)10.1038/s41598-022-11843-z
N/A
0DataRank · unranked
8 citations

Chang Li, Hongjie Wang, Swarnendu Kaviraj, Sanjay Singh, Laxman Savergave +11 more

Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer

Cell(2023)10.1016/j.cell.2023.07.004
N/A
0DataRank · unranked
91 citations

Jacob J. Kennedy, Richard G. Ivey, Oscar Murillo, Noshad Hosseini, Xiaoyu Song +42 more

The 2022 NCI Community Oncology Research Program (NCORP) Landscape Committee Assessment: Methods and participating practice group characteristics.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13517
N/A
0DataRank · unranked
5 citations

Emily V. Dressler, Andrew M. McDonald, Heather B. Neuman, Susan K. Parsons, Melyssa Foust +12 more

Sexual Orientation and Gender Identity Data Collection in Cancer Care: A Nationwide Landscape Assessment Update

JCO Oncology Practice(2024)10.1200/op.23.00724
N/A
0DataRank · unranked
23 citations

Aminah Jatoi, Emily V. Dressler, Carol Kittel, Kathryn E. Weaver, Chandylen L. Nightingale +14 more

Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer

Cell(2024)10.1016/j.cell.2024.01.016
N/A
0DataRank · unranked
11 citations

Jacob J. Kennedy, Richard G. Ivey, Oscar Murillo, Noshad Hosseini, Xiaoyu Song +42 more

Desmoglein-2 as a prognostic and biomarker in ovarian cancer

Cancer Biology & Therapy(2020)10.1080/15384047.2020.1843323
N/A
0DataRank · unranked
30 citations

Peter G. Beidler, Hongjie Wang, Chang Li, Abdullah Quassab, Cari Coles +4 more

Whole-Proteome Screening and Multi-Modal Profiling of Antigen-Specific CD4+ T Cells at Single-Cell Resolution

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.21.649828
N/A
0DataRank · unranked
0 citations

Qi Jin, Michaela McKasson, Jongchan Choi, Vanessa Gutiérrez, Conor Brennan +35 more